Neokem Labs Private Limited

Neokem Labs Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24299DL2021PTC384262 Incorporated 27 July 2021 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹1.34 Cr
▲ 475% YoY
Net loss · FY 2023
₹52.73 Lakh
Net margin -39.5%
EBITDA · FY 2023
-₹50.72 Lakh
EBITDA margin -38%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹24 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
29
Provident fund records

About Neokem Labs Private Limited

Data last updated:

Neokem Labs Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC384262. Its GSTIN is 07AAHCN7223L1Z6 (Delhi).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arun Kumar and Sanjay Bansal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14/18 G/F Patel Nagar Road East Patel Nagar, Delhi, India – 110008.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.34 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹52.73 Lakh (net margin -39.5%) and EBITDA of -₹50.72 Lakh (EBITDA margin -38%).

The company has about 29 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹24 Lakh on record.

Neokem Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0010551).

Company details

CIN U24299DL2021PTC384262
Registration Number 384262
Incorporation Date 27 July 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0010551

Recognitions & Rankings of Neokem Labs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-01-0010551

Contact details

Neokem Labs Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    14/18 G/F Patel Nagar Road East Patel Nagar, Delhi, India – 110008
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Neokem Labs Private Limited, buy the company report.

Comprehensive company report
Neokem Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Neokem Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Neokem Labs Private Limited, buy the company report.

Financials of Neokem Labs Private Limited

FY 2025 filings available

Neokem Labs Private Limited reported revenue of ₹1.34 Cr (up 475% YoY) for FY 2023.

Revenue · FY 2023
₹1.34 Cr ▲ 475%
Net loss · FY 2023
₹52.73 Lakh margin -39.5%
EBITDA · FY 2023
-₹50.72 Lakh margin -38%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 475%
EBITDA CAGR growth
1 year
▼ 718%

Revenue rose 475% in the latest year. EBITDA fell 718% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹1.34 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹50.72 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹52.73 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin-38%
Net Profit Margin-39.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neokem Labs Private Limited, buy the company report.

Board of directors of Neokem Labs Private Limited

Neokem Labs has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun KumarDirector27 Jul 20215 Years 3 MonthsCurrent
Sanjay BansalDirector27 Jul 20215 Years 3 MonthsCurrent
Seema SharmaDirector27 Jul 20215 Years 3 MonthsCurrent
Rakesh SharmaDirector27 Jul 20215 Years 3 MonthsCurrent

Peer comparison

Neokem Labs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Symlek Healthcare Private Limited₹1.34 Cr (FY 2024)169.0%Mohali, Punjab, India
Mitasa Chemicals Pvt Ltd₹1.34 Cr (FY 2025)7.0%Siliguri, West Bengal, India
Medigrand Pharmaceuticals Private Limited₹1.34 Cr (FY 2022)43.0%Harur, Tamil Nadu, India
Anabolic Remedies Private Limited₹1.34 Cr (FY 2025)-7.0%Chandigarh, India
Nature Pure Supercritical Extracts Private Limited₹1.34 Cr (FY 2024)-56.0%Mumbai, Maharashtra, India
Neokem Labs Private Limitedthis company₹1.34 Cr (FY 2023)-₹52.73 Lakh-39.5%475.0%29Delhi, India
Medox Biotech India Private Limited₹1.33 Cr (FY 2024)-22.0%Chennai, Tamil Nadu, India
Adi Diagnostics Private Limited₹1.33 Cr (FY 2025)1.0%Lakdikapool, Hyderabd-4, Telangana, India
Sesola Facility Services and Security Agency Private Limited₹1.33 Cr (FY 2025)-76.0%Hyderabad, Telangana, India
Mimulus Laboratories Private Limited₹1.33 Cr (FY 2025)1223.0%Puducherry, India
Quantum Naturals India Private Limited₹1.33 Cr (FY 2023)115.0%Gurugram, Haryana, India

To see the full peer comparison of Neokem Labs Private Limited, buy the company report.

Auditor

Neokem Labs Private Limited is audited by CHANDER PARKASH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
CHANDER PARKASH & CO.FY 2023010770N

Shareholding

The shareholding of Neokem Labs Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Neokem Labs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹24 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.24 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Mar 2023100691593Others₹24 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

Neokem Labs Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 14 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
an individual supplier

To see the full MSME payment records of Neokem Labs Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Neokem Labs Private Limited has a workforce of 29 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.

Employee count
29
Active EPFO establishments
1
Employee growth
-12.12%

GST

Neokem Labs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAHCN7223L1Z6DelhiActive25 Aug 2021

To see the full GST registrations and return filing status of Neokem Labs Private Limited, buy the company report.

Recent activity

Neokem Labs Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Arun Kumar was appointed as Director on 27 Jul 2021.

AGM
Neokem Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neokem Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 24.00 Lakh with Charge ID 100691593 was registered on 04 Mar 2023.
Appointed
Arun Kumar was appointed as Director.
Appointed
Rakesh Sharma was appointed as Director.
Appointed
Sanjay Bansal was appointed as Director.
Appointed
Seema Sharma was appointed as Director.
Incorporation
27 Jul 2021
Neokem Labs Private Limited was registered on 27 Jul 2021 with Roc Delhi Ii & aged 5 years 3 months as per MCA records.

Frequently asked questions

Neokem Labs is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2021 (5+ years old) and is registered under CIN U24299DL2021PTC384262.

Neokem Labs has 4 current directors:

The latest financial statements of Neokem Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Neokem Labs is 07AAHCN7223L1Z6, registered in Delhi.

The CIN (Corporate Identification Number) of Neokem Labs is U24299DL2021PTC384262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neokem Labs was incorporated on 27 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Neokem Labs by revenue are Symlek Healthcare Private Limited, Mitasa Chemicals Pvt Ltd, Medigrand Pharmaceuticals Private Limited, Anabolic Remedies Private Limited, Nature Pure Supercritical Extracts Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Arun Kumar was appointed as Director on 27 Jul 2021. Rakesh Sharma was appointed as Director on 27 Jul 2021. Sanjay Bansal was appointed as Director on 27 Jul 2021. Neokem Labs has 4 board changes on record in total.

Yes, Neokem Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0010551).

Neokem Labs has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 14 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Aug 2023.

The registered office of Neokem Labs is at 1418 GF Patel Nagar Road East Patel Nagar, Delhi, India – 110008.

Neokem Labs operates in the pharma industry, in the drug formulation and development segment.